greeksoup/ stock research

Ecovyst Inc.: Q3 FY2026 earnings call

What management said about Q3 FY2026, from the documents filed with the SEC on 5 November 2026: press release. Guidance figures: 6 raised, 2 narrowed, 1 new, 1 kept. The quarter’s numbers.

Key takeaways

  • Sales rose 51% on volume and pricing: Sales rose $103.7 million on higher volume and pricing, plus Calabrian sales from June 30, 2026. Pass-through of higher sulfur costs was a major part of the pricing gain. Source
  • Adjusted EBITDA rose 6%: Adjusted EBITDA increased $3.7 million, driven by higher sales volume and net pricing, partly offset by manufacturing, inflation and transportation costs. Source
  • Full-year ranges raised: The company raised most full-year 2026 ranges, including sales, Adjusted EBITDA and Adjusted Free Cash Flow. Source
  • Regenerated acid volumes and sales grew: Management attributed regenerated acid growth to refining margins and increased export demand, which raised volumes and sales year over year. Source
  • Sulfur pass-through lifted selling prices: Average selling prices rose mainly because of the pass-through of higher sulfur costs, of about $67 million, and favorable contractual pricing for regenerated acid. Source
  • Calabrian in results for first full quarter: Results include the Calabrian sulfur dioxide and derivatives business, acquired June 30, 2026, which management describes as the first full quarter of ownership. Source
  • Net debt leverage rose to 2.1x: The Net Debt Leverage Ratio was 2.1x, up from 1.2x at year-end, due to the $100 million term loan increase for Calabrian with one quarter of its EBITDA in trailing twelve months. Source

“Ecovyst delivered another strong quarter, with third quarter 2026 Adjusted EBITDA of $61 million, up over 6% compared to the year-ago quarter, and above the high end of our guidance range”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Sales Sourcefull year 2026$1,050 million to $1,070 millionRaised from $1,020 million to $1,060 million
Adjusted EBITDA Sourcefull year 2026approximately $208 million to $212 millionRaised from $195 million to $207 million
Adjusted Free Cash Flow Sourcefull year 2026$50 million to $60 millionRaised from $45 million to $55 million
Capital expenditures Sourcefull year 2026$90 million to $95 millionNarrowed, low end up from $85 million to $95 million
Interest expense Sourcefull year 2026$19 million to $21 million
Depreciation and amortization Sourcefull year 2026$84 million to $88 millionRaised from $80 million to $84 million
Effective tax rate Sourcefull year 2026mid 20% rangeKept
Adjusted Net Income Sourcefull year 2026$70 million to $85 millionNarrowed, low end up from $65 million to $85 million
Adjusted Diluted Income per share Sourcefull year 2026$0.63 to $0.77Raised from $0.58 to $0.72
Sulfur pass-through in sales Sourcefull year 2026approximately $220 millionRaised from approximately $155 million
Share repurchases Sourcesecond half 2026up to $20 millionNew

What changed from last quarter

  • Guidance raised: Full-year ranges raised for sales, Adjusted EBITDA, Adjusted Free Cash Flow, depreciation and amortization, Adjusted Net Income and Adjusted diluted income per share. Source
  • Guidance raised: Projected sulfur pass-through in the full-year sales assumption raised from about $155 million. Source
  • New guidance: Second-half 2026 share repurchase intent stated. The prior release gave no repurchase figure for that period. Source

Results and growth drivers

  • Sales rose 51% on volume and pricing: Sales rose $103.7 million on higher volume and pricing, plus Calabrian sales from June 30, 2026. Pass-through of higher sulfur costs was a major part of the pricing gain. Source
  • Adjusted EBITDA rose 6%: Adjusted EBITDA increased $3.7 million, driven by higher sales volume and net pricing, partly offset by manufacturing, inflation and transportation costs. Source
  • Net income and diluted EPS rose: Net income from continuing operations was $18.4 million, against $0.2 million a year earlier. Diluted EPS was $0.17, with a net income margin of 6.0%. Source
  • Adjusted net income and EPS rose: Adjusted Net Income was $25.3 million, compared with $21.5 million a year earlier, and Adjusted Diluted Income per share was $0.23. Source
  • Full-year ranges raised: The company raised most full-year 2026 ranges, including sales, Adjusted EBITDA and Adjusted Free Cash Flow. Source

Products and end markets

  • Regenerated acid volumes and sales grew: Management attributed regenerated acid growth to refining margins and increased export demand, which raised volumes and sales year over year. Source
  • Virgin acid sales increased: Virgin sulfuric acid sales rose on mining demand, stable industrial demand and pricing fundamentals, according to management. Source
  • Canadian gold mine rates expected high: Management expects high operating rates at Canadian gold mines to continue in the fourth quarter, supporting Calabrian sulfur dioxide sales. Source

“We remain flexible in how we allocate capital while prioritizing stockholder value.”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Costs, margins and pricing

  • Sulfur pass-through lifted selling prices: Average selling prices rose mainly because of the pass-through of higher sulfur costs, of about $67 million, and favorable contractual pricing for regenerated acid. Source
  • Adjusted EBITDA margin was 19.8%: Adjusted EBITDA margin from continuing operations was 19.8% for the quarter, against 28.1% in the year-ago quarter. Source
  • Higher costs partly offset gains: Higher manufacturing costs, general inflation and higher transportation costs partly offset the gains in Adjusted EBITDA this quarter. Source

Demand and refinery utilization

  • High refinery utilization expected through year-end: Given current refining economics, management expects high refinery utilization through year-end and demand across the portfolio to remain healthy for the rest of the year. Source
  • Copper mining demand to keep growing: Management expects ongoing growth in copper mining demand for virgin sulfuric acid to keep benefiting sales. Source
  • Demand for both acids seen positive: Management expects demand for regenerated and virgin sulfuric acid to remain positive for the rest of 2026. Source

Calabrian integration

  • Calabrian in results for first full quarter: Results include the Calabrian sulfur dioxide and derivatives business, acquired June 30, 2026, which management describes as the first full quarter of ownership. Source
  • Calabrian performance consistent with thesis: Management said Calabrian's third-quarter performance was consistent with the company's investment thesis. Source

Cash flow and balance sheet

  • Nine-month operating cash flow rose: Operating cash flow from continuing operations was $80.7 million for nine months, against $77.0 million a year earlier, mainly from higher earnings excluding non-cash items. Source
  • Nine-month adjusted free cash flow lower: Adjusted Free Cash Flow was $32.4 million for nine months, compared with $42.4 million a year earlier. Source
  • Net debt leverage rose to 2.1x: The Net Debt Leverage Ratio was 2.1x, up from 1.2x at year-end, due to the $100 million term loan increase for Calabrian with one quarter of its EBITDA in trailing twelve months. Source
  • Liquidity totaled $167.0 million: Total liquidity was $167.0 million: $71.2 million of cash plus $95.8 million of ABL availability. Gross debt was $497.1 million. Source

Share repurchases and capital allocation

  • Third-quarter repurchases totaled $2.7 million: The company repurchased 263,719 shares in the third quarter at an average price of $10.25, for a total cost of $2.7 million. Source
  • $143.8 million left on authorization: As of September 30, 2026, $143.8 million remained available for repurchases under the program approved in April 2022. Source
  • Capital allocation weighs growth and returns: Management said it allocates capital flexibly, weighing organic and inorganic growth alongside returns to stockholders through share repurchases. Source

Discontinued operations and tax items

  • Advanced Materials business sale completed: The Advanced Materials & Catalysts business, including the Zeolyst investments, was sold on December 31, 2025, and is reported as discontinued operations. Source
  • Discontinued operations loss in quarter: The net loss from discontinued operations was $0.2 million in the quarter, against $79.5 million in the year-ago quarter. Source
  • State tax valuation allowance recorded: A valuation allowance was recorded on state tax attributes. Management treats it as a non-cash addback in Adjusted Net Income. Source
  • Effective tax rate 19.9% for quarter: The effective tax rate was 19.9% for the quarter and 26.2% for nine months. Source

Coming up, as management said on 5 November 2026

  • Turnaround moves into early 2027: Management said a turnaround shifts from the fourth quarter into early 2027, which is reflected in the raised full-year Adjusted EBITDA range. Source

Risks management discussed

  • Operational: Management said it remains cautious about unplanned outages at refining customers, which could affect demand for regenerated acid. Source
  • External: A significant drop in sulfur prices could lead to short-term customer destocking, according to management. Source

Earlier plans management reported on

  • On track: Management said Calabrian integration is underway and the company remains on track to capture anticipated synergies. Source
  • Ahead: Management said third-quarter Adjusted EBITDA was above the high end of the guidance range it had given. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.